Nicotine and the adolescent brain

Journal of Physiology

Volumn 593, Issue 16, 2015, Pages 3397-3412

  Yuan, Menglu ^a   Cross, Sarah J ^b   Loughlin, Sandra E ^a   Leslie, Frances M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; DOPAMINE; DOPAMINE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINE; NICOTINIC RECEPTOR; SEROTONIN TRANSPORTER; NICOTINIC AGENT;

ADOLESCENCE; ADOLESCENT; ADOLESCENT BEHAVIOR; ADOLESCENT SMOKING; ADULTHOOD; BRAIN; BRAIN DEVELOPMENT; BRAIN FUNCTION; CHEMOSENSITIVITY; COGNITION; DOPAMINERGIC SYSTEM; ELECTRONIC CIGARETTE; HUMAN; LONG TERM EXPOSURE; NEUROBIOLOGY; NEUROCHEMISTRY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TOBACCO DEPENDENCE; ADOLESCENT DEVELOPMENT; ANIMAL; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; PHYSIOLOGY;

ADOLESCENT; ADOLESCENT DEVELOPMENT; ANIMALS; BRAIN; HUMANS; NICOTINE; NICOTINIC AGONISTS;

EID: 84938950848     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP270492     Document Type: Review

References (190)

1. Adriani W, Macri S, Pacifici R & Laviola G (2002). Peculiar vulnerability to nicotine oral self-administration in mice during early adolescence. Neuropsychopharmacology 27, 212-224.
2. Adriani W, Spijker S, Deroche-Gamonet V, Laviola G, Le Moal M, Smit AB & Piazza PV (2003). Evidence for enhanced neurobehavioral vulnerability to nicotine during periadolescence in rats. J Neurosci 23, 4712-4716.
3. Aksglaede L, Sørensen K, Petersen JH, Skakkebaek NE & Juul A (2009). Recent decline in age at breast development: the Copenhagen Puberty Study. Pediatrics 123, e932-939.
4. Albuquerque EX, Pereira EF, Alkondon M & Rogers SW (2009). Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev 89, 73-120.
5. Albuquerque EX, Pereira EF, Braga MF & Alkondon M (1998). Contribution of nicotinic receptors to the function of synapses in the central nervous system: the action of choline as a selective agonist of α7 receptors. J Physiol Paris 92, 309-316.
6. Andersen SL, Rutstein M, Benzo JM, Hostetter JC & Teicher MH (1997). Sex differences in dopamine receptor overproduction and elimination. Neuroreport 8, 1495-1498.
7. Andersen SL, Thompson AT, Rutstein M, Hostetter JC & Teicher MH (2000). Dopamine receptor pruning in prefrontal cortex during the periadolescent period in rats. Synapse 37, 167-169.
8. Anthony JC (2012). James C. Anthony on Zili Sloboda's "The state of support for research on the epidemiology, prevention, and treatment of drug use and drug use disorders in the USA." Subst Use Misuse 47, 1571-1574.
9. Auger ML, Schmidt ER, Manitt C, Dal-Bo G, Pasterkamp RJ & Flores C (2013). unc5c haploinsufficient phenotype: striking similarities with the dcc haploinsufficiency model. Eur J Neurosci 38, 2853-2863.
10. Azam L, Chen Y & Leslie FM (2007). Developmental regulation of nicotinic acetylcholine receptors within midbrain dopamine neurons. Neuroscience 144, 1347-1360.
11. Baarendse PH, Counotte DS, O'Donnell P & Vanderschuren LJ (2013). Early social experience is critical for the development of cognitive control and dopamine modulation of prefrontal cortex function. Neuropsychopharmacology 38, 1485-1494.
12. Bang SJ & Commons KG (2011). Age-dependent effects of initial exposure to nicotine on serotonin neurons. Neuroscience 179, 1-8.
13. Belluzzi JD, Lee AG, Oliff HS & Leslie FM (2004). Age-dependent effects of nicotine on locomotor activity and conditioned place preference in rats. Psychopharmacology (Berl) 174, 389-395.
14. 2 dopamine modulation of corticoaccumbens synaptic responses changes during adolescence. Eur J Neurosci 27, 1364-1372.
15. Bergstrom HC, McDonald CG, French HT & Smith RF (2008). Continuous nicotine administration produces selective, age-dependent structural alteration of pyramidal neurons from prelimbic cortex. Synapse 62, 31-39.
16. Bernheim A, Halfon O & Boutrel B (2013). Controversies about the enhanced vulnerability of the adolescent brain to develop addiction. Front Pharmacol 4, 118.
17. Biederman J, Monuteaux MC, Mick E, Wilens TE, Fontanella JA, Poetzl KM, Kirk T, Masse J & Faraone SV (2006). Is cigarette smoking a gateway to alcohol and illicit drug use disorders? A study of youths with and without attention deficit hyperactivity disorder. Biol Psychiatry 59, 258-264.
18. Biro FM, Greenspan LC, Galvez MP, Pinney SM, Teitelbaum S, Windham GC, Deardorff J, Herrick RL, Succop PA, Hiatt RA, Kushi LH & Wolff MS (2013). Onset of breast development in a longitudinal cohort. Pediatrics 132, 1019-1027.
19. Brenhouse HC, Sonntag KC & Andersen SL (2008). Transient D1 dopamine receptor expression on prefrontal cortex projection neurons: relationship to enhanced motivational salience of drug cues in adolescence. J Neurosci 28, 2375-2382.
20. Brielmaier JM, McDonald CG & Smith RF (2007). Immediate and long-term behavioral effects of a single nicotine injection in adolescent and adult rats. Neurotoxicol Teratol 29, 74-80.
21. Britton AF, Vann RE & Robinson SE (2007). Perinatal nicotine exposure eliminates peak in nicotinic acetylcholine receptor response in adolescent rats. J Pharmacol Exp Ther 320, 871-876.
22. Brody AL, Mandelkern MA, London ED, Olmstead RE, Farahi J, Scheibal D, Jou J, Allen V, Tiongson E, Chefer SI, Koren AO & Mukhin AG (2006). Cigarette smoking saturates brain α4β2 nicotinic acetylcholine receptors. Arch Gen Psychiatry 63, 907-915.
23. Broide RS & Leslie FM (1999). The α7 nicotinic acetylcholine receptor in neuronal plasticity. Mol Neurobiol 20, 1-16.
24. Bunnell RE, Agaku IT, Arrazola RA, Apelberg BJ, Caraballo RS, Corey CG, Coleman BN, Dube SR & King BA (2015). Intentions to smoke cigarettes among never-smoking us middle and high school electronic cigarette users: National Youth Tobacco Survey, 2011-2013. Nicotine Tob Res 17, 228-235.
25. Burke AR & Miczek K (2014). Stress in adolescence and drugs of abuse in rodent models: role of dopamine, CRF, and HPA axis. Psychopharmacology (Berl) 231, 1557-1580.
26. Burke MV, Ebbert JO & Hays JT (2008). Treatment of tobacco dependence. Mayo Clinic Proc 83, 479-483.
27. Cabrera SM, Bright GM, Frane JW, Blethen SL & Lee PA (2014). Age of thelarche and menarche in contemporary US females: a cross-sectional analysis. J Pediatr Endocrinol Metab 27, 47-51.
28. Camenga DR, Delmerico J, Kong G, Cavallo D, Hyland A, Cummings KM & Krishnan-sarin S (2014). Trends in use of electronic nicotine delivery systems by adolescents. Addict Behav 39, 338-340.
29. Cao J, Belluzzi JD, Loughlin SE, Dao JM, Chen Y & Leslie FM (2010). Locomotor and stress responses to nicotine differ in adolescent and adult rats. Pharmacol Biochem Behav 96, 82-90.
30. Cao J, Lotfipour S, Loughlin SE & Leslie FM (2007). Adolescent maturation of cocaine-sensitive neural mechanisms. Neuropsychopharmacology 32, 2279-2289.
31. 3H]dopamine release from hippocampus. J Pharmacol Exp Ther 312, 1298-1304.
32. Casey B, Jones RM & Somerville LH (2011). Braking and accelerating of the adolescent brain. J Res Adolesc 21, 21-33.
33. Cengelli S, O'Loughlin J, Lauzon B & Cornuz J (2012). A systematic review of longitudinal population-based studies on the predictors of smoking cessation in adolescent and young adult smokers. Tob Control 21, 355-362.
34. Centers for Disease Control and Prevention (2013). Notes from the field: electronic cigarette use among middle and high school students - United States, 2011-2012. MMWR Morb Mortal Wkly Rep 62, 729-730.
35. Chambers RA, Taylor JR & Potenza MN (2003). Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry 160, 1041-1052.
36. Cheeta S, Irvine EE, Tucci S, Sandhu J & File SE (2001). In adolescence, female rats are more sensitive to the anxiolytic effect of nicotine than are male rats. Neuropsychopharmacology 25, 601-607.
37. Chen H, Matta SG & Sharp BM (2007). Acquisition of nicotine self-administration in adolescent rats given prolonged access to the drug. Neuropsychopharmacology 32, 700-709.
38. Chen P & Jacobson KC (2012). Developmental trajectories of substance use from early adolescence to young adulthood: gender and racial/ethnic differences. J Adolesc Health 50, 154-163.
39. Collins SL, Wade D, Ledon J & Izenwasser S (2004). Neurochemical alterations produced by daily nicotine exposure in periadolescent vs. adult male rats. Eur J Pharmacol 502, 75-85.
40. Counotte DS, Goriounova NA, Li KW, Loos M, van der Schors RC, Schetters D, Schoffelmeer AN, Smit AB, Mansvelder HD, Pattij T & Spijker S (2011). Lasting synaptic changes underlie attention deficits caused by nicotine exposure during adolescence. Nat Neurosci 14, 417-419.
41. Counotte DS, Spijker S, Van de Burgwal LH, Hogenboom F, Schoffelmeer AN, De Vries TJ, Smit AB & Pattij T (2009). Long-lasting cognitive deficits resulting from adolescent nicotine exposure in rats. Neuropsychopharmacology 34, 299-306.
42. Crews F, He J & Hodge C (2007). Adolescent cortical development: a critical period of vulnerability for addiction. Pharmacol Biochem Behav 86, 189-199.
43. Dahl RE (2008). Biological, developmental, and neurobehavioral factors relevant to adolescent driving risks. Am J Prev Med 35, S278-284.
44. Dani JA & Balfour DJ (2011). Historical and current perspective on tobacco use and nicotine addiction. Trends Neurosci 34, 383-392.
45. Dani JA & Bertrand D (2007). Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 47, 699-729.
46. 1A receptor mechanism. Neuropsychopharmacology 36, 1319-1331.
47. Degenhardt L, Dierker L, Chiu WT, Medina-Mora ME, Neumark Y, Sampson N, Alonso J, Angermeyer M, Anthony JC, Bruffaerts R, de Girolamo G, de Graaf R, Gureje O, Karam AN, Kostyuchenko S, Lee S, Lépine J-P, Levinson D, Nakamura Y, Posada-Villa J, Stein D, Wells JE & Kessler RC (2010). Evaluating the drug use "gateway" theory using cross-national data: consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health Surveys. Drug Alcohol Depend 108, 84-97.
48. Doura MB, Gold AB, Keller AB & Perry DC (2008). Adult and periadolescent rats differ in expression of nicotinic cholinergic receptor subtypes and in the response of these subtypes to chronic nicotine exposure. Brain Res 1215, 40-52.
49. Dutra LM & Glantz SA (2014). Electronic cigarettes and conventional cigarette use among U.S. adolescents: a cross-sectional study. JAMA Pediatr 168, 610-617.
50. Dwyer JB, Broide RS & Leslie FM (2008). Nicotine and brain development. Birth Defects Res C Embryo Today 84, 30-44.
51. Dwyer JB, McQuown SC & Leslie FM (2009). The dynamic effects of nicotine on the developing brain. Pharmacol Ther 122, 125-139.
52. Ehlinger DG, Bergstrom HC, Burke JC, Fernandez GM, McDonald CG & Smith RF (2015). Adolescent nicotine-induced dendrite remodeling in the nucleus accumbens is rapid, persistent, and D1-dopamine receptor dependent. Brain Struct Funct (in press, doi: 10.1007/s00429-014-0897-3)
53. Elliott BM, Faraday MM, Phillips JM & Grunberg NE (2004). Effects of nicotine on elevated plus maze and locomotor activity in male and female adolescent and adult rats. Pharmacol Biochem Behav 77, 21-28.
54. Euling SY, Herman-Giddens ME, Lee PA, Selevan SG, Juul A, Sørensen TIA, Dunkel L, Himes JH, Teilmann G & Swan SH (2008). Examination of US puberty-timing data from 1940 to 1994 for secular trends: panel findings. Pediatrics 121 Suppl, S172-191.
55. Fair DA, Cohen AL, Power JD, Dosenbach NU, Church JA, Miezin FM, Schlaggar BL & Petersen SE (2009). Functional brain networks develop from a "local to distributed" organization. PLoS Comput Biol 5, e1000381.
56. 2 mRNA expression. Behav Brain Res 260, 25-33.
57. Farrelly MC, Loomis BR, Han B, Gfroerer J, Kuiper N, Couzens GL, Dube S & Caraballo RS (2013). A comprehensive examination of the influence of state tobacco control programs and policies on youth smoking. Am J Public Health 103, 549-555.
58. Fenster CP, Hicks JH, Beckman ML, Covernton PJ, Quick MW & Lester RA (1999). Desensitization of nicotinic receptors in the central nervous system. Ann N Y Acad Sci 868, 620-623.
59. Flensborg-Madsen T, von Scholten MB, Flachs EM, Mortensen EL, Prescott E & Tolstrup JS (2011). Tobacco smoking as a risk factor for depression. A 26-year population-based follow-up study. J Psychiatr Res 45, 143-149.
60. Flores-Barrera E, Thomases DR, Heng LJ, Cass DK, Caballero A & Tseng KY (2014). Late adolescent expression of GluN2B transmission in the prefrontal cortex is input-specific and requires postsynaptic protein kinase A and D1 dopamine receptor signaling. Biol Psychiatry 75, 508-516.
61. Forbes EE & Dahl RE (2010). Pubertal development and behavior: hormonal activation of social and motivational tendencies. Brain Cogn 72, 66-72.
62. Fowler CD, Lu Q, Johnson PM, Marks MJ & Kenny PJ (2011). Habenular α5 nicotinic receptor subunit signalling controls nicotine intake. Nature 471, 597-601.
63. Gallego X, Molas S, Amador-Arjona A, Marks MJ, Robles N, Murtra P, Armengol L, Fernandez-Montes RD, Gratacos M, Pumarola M, Cabrera R, Maldonado R, Sabria J, Estivill X & Dierssen M (2012). Overexpression of the CHRNA5/A3/B4 genomic cluster in mice increases the sensitivity to nicotine and modifies its reinforcing effects. Amino Acids 43, 897-909.
64. Garske AK, Lawyer CR, Peterson BM & Illig KR (2013). Adolescent changes in dopamine D1 receptor expression in orbitofrontal cortex and piriform cortex accompany an associative learning deficit. PLoS One 8, e56191.
65. Giedd JN, Blumenthal J, Jeffries NO, Castellanos FX, Liu H, Zijdenbos A, Paus T, Evans AC & Rapoport JL (1999). Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci 2, 861-863.
66. Ginzel KH, Maritz GS, Marks DF, Neuberger M, Pauly JR, Polito JR, Schulte-Hermann R & Slotkin TA (2007). Critical review: nicotine for the fetus, the infant and the adolescent? J Health Psychol 12, 215-224.
67. Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D, Vaituzis AC, Nugent TF 3rd, Herman DH, Clasen LS, Toga AW, Rapoport JL & Thompson PM (2004). Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A 101, 8174-8179.
68. Gogtay N & Thompson PM (2010). Mapping gray matter development: Implications for typical development and vulnerability to psychopathology. Brain Cogn 72, 6-15.
69. Goriounova NA & Mansvelder HD (2012). Nicotine exposure during adolescence leads to short- and long-term changes in spike timing-dependent plasticity in rat prefrontal cortex. J Neurosci 32, 10484-10493.
70. Gotti C & Clementi F (2004). Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol 74, 363-396.
71. Gotti C, Zoli M & Clementi F (2006). Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol Sci 27, 482-491.
72. Grace AA, Floresco SB, Goto Y & Lodge DJ (2007). Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci 30, 220-227.
73. Grady SR, Moretti M, Zoli M, Marks MJ, Zanardi A, Pucci L, Clementi F & Gotti C (2009). Rodent habenulo-interpeduncular pathway expresses a large variety of uncommon nAChR subtypes, but only the α3β4* and α3β3β4* subtypes mediate acetylcholine release. J Neurosci 29, 2272-2282.
74. Grana R, Benowitz N & Glantz SA (2014). E-cigarettes: a scientific review. Circulation 129, 1972-1986.
75. Grant A, Hoops D, Labelle-Dumais C, Prevost M, Rajabi H, Kolb B, Stewart J, Arvanitogiannis A & Flores C (2007). Netrin-1 receptor-deficient mice show enhanced mesocortical dopamine transmission and blunted behavioral responses to amphetamine. Eur J Neurosci 26, 3215-2128.
76. Grant A, Speed Z, Labelle-Dumais C & Flores C (2009). Post-pubertal emergence of dopamine phenotype in netrin-1 receptor-deficient mice. Eur J Neurosci 30, 1318-1328.
77. Hagen CP, Sørensen K, Aksglaede L, Mouritsen A, Mieritz MG, Tinggaard J, Wohlfart-Veje C, Petersen JH, Main KM, Rajpert-De Meyts E, Almstrup K & Juul A (2014). Pubertal onset in girls is strongly influenced by genetic variation affecting FSH action. Sci Rep 4, 6412.
78. Hanna EZ, Yi H, Dufour MC & Whitmore CC (2001). The relationship of early-onset regular smoking to alcohol use, depression, illicit drug use, and other risky behaviors during early adolescence: Results from the youth supplement to the Third National Health and Nutrition Examination Survey. J Subst Abuse 13, 265-282.
79. Hollenstein T & Lougheed JP (2013). Beyond storm and stress: Typicality, transactions, timing, and temperament to account for adolescent change. Am Psychol 68, 444-454.
80. Huang YY, Kandel DB, Kandel ER & Levine A (2013). Nicotine primes the effect of cocaine on the induction of LTP in the amygdala. Neuropharmacology 74, 126-134.
81. Huang YY, Levine A, Kandel DB, Yin D, Colnaghi L, Drisaldi B & Kandel ER (2014). D1/D5 receptors and histone deacetylation mediate the Gateway Effect of LTP in hippocampal dentate gyrus. Learn Mem 21, 153-160.
82. Huppé-Gourgues F & O'Donnell P (2012a). D1-NMDA receptor interactions in the rat nucleus accumbens change during adolescence. Synapse 66, 584-591.
83. 2-AMPA interactions in the rat nucleus accumbens. Synapse 66, 1-8.
84. Hwang K, Velanova K & Luna B (2010). Strengthening of top-down frontal cognitive control networks underlying the development of inhibitory control: a functional magnetic resonance imaging effective connectivity study. J Neurosci 30, 15535-15545.
85. Iñiguez SD, Warren BL, Parise EM, Alcantara LF, Schuh B, Maffeo ML, Manojlovic Z & Bolaños-Guzman CA (2009). Nicotine exposure during adolescence induces a depression-like state in adulthood. Neuropsychopharmacology 34, 1609-1624.
86. Jackson C, Geddes R, Haw S & Frank J (2012). Interventions to prevent substance use and risky sexual behavior in young people: a systematic review. Addiction 107, 733-747.
87. John U, Meyer C, Rumpf HJ & Hapke U (2004). Smoking, nicotine dependence and psychiatric comorbidity - a population-based study including smoking cessation after three years. Drug Alcohol Depend 76, 287-295.
88. Kandel DB, Yamaguchi K & Chen K (1992). Stages of progression in drug involvement from adolescence to adulthood: further evidence for the gateway theory. J Stud Alcohol 53, 447-457.
89. Kandel ER & Kandel DB (2014). A molecular basis for nicotine as a gateway drug. N Engl J Med 371, 932-943.
90. Kawai HD, Kang HA & Metherate R (2011). Heightened nicotinic regulation of auditory cortex during adolescence. J Neurosci 31, 14367-14377.
91. Kendler KS, Myers J, Damaj MI & Chen X (2014). Early smoking onset and risk for subsequent nicotine dependence: a monozygotic co-twin control study. Am J Psychiatry 170, 408-413.
92. Klungsoyr O, Nygard JF, Sorensen T & Sandanger I (2006). Cigarette smoking and incidence of first depressive episode: an 11-year, population-based follow-up study. Am J Epidemiol 163, 421-432.
93. Kollins SH & Adcock RA (2014). ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: implications for smoking and nicotine dependence. Prog Neuropsychopharmacol Biol Psychiatry 52, 70-78.
94. Kota D, Martin BR, Robinson SE & Damaj MI (2007). Nicotine dependence and reward differ between adolescent and adult male mice. J Pharmacol Exp Ther 322, 399-407.
95. Kremer I, Bachner-Melman R, Reshef A, Broude L, Nemanov L, Gritsenko I, Heresco-Levy U, Elizur Y & Ebstein RP (2005). Association of the serotonin transporter gene with smoking behavior. Am J Psychiatry 162, 924-930.
96. Lai S, Lai H, Page JB & McCoy CB (2000). The association between cigarette smoking and drug abuse in the United States. J Addict Dis 19, 11-24.
97. Laviola G, Macrì S, Morley-Fletcher S & Adriani W (2003). Risk-taking behavior in adolescent mice: psychobiological determinants and early epigenetic influence. Neurosci Biobehav Rev 27, 19-31.
98. Laviola G, Pascucci T & Pieretti S (2001). Striatal dopamine sensitization to D-amphetamine in periadolescent but not in adult rats. Pharmacol Biochem Behav 68, 115-124.
99. Lee S, Grana RA & Glantz SA (2014). Electronic cigarette use among Korean adolescents: a cross-sectional study of market penetration, dual use, and relationship to quit attempts and former smoking. J Adolesc Health 54, 684-690.
100. Lenoir M, Starosciak AK, Ledon J, Booth C, Zakharova E, Wade D, Vignoli B & Izenwasser S (2015). Sex differences in conditioned nicotine reward are age-specific. Pharmacol Biochem Behav 132, 56-62.
101. Leslie FM (2013). Multigenerational epigenetic effects of nicotine on lung function. BMC Med 11, 27.
102. Leslie FM, Loughlin SE, Wang R, Perez L, Lotfipour S & Belluzzi JD (2004). Adolescent development of forebrain stimulant responsiveness: insights from animal studies. Ann N Y Acad Sci 1021, 148-159.
103. Leslie FM, Mojica CY & Reynaga DD (2013). Nicotinic receptors in addiction pathways. Mol Pharmacol 83, 753-758.
104. Levin ED, Lawrence SS, Petro A, Horton K, Rezvani AH, Seidler FJ & Slotkin TA (2007). Adolescent vs. adult-onset nicotine self-administration in male rats: duration of effect and differential nicotinic receptor correlates. Neurotoxicol Teratol 29, 458-465.
105. Levine A, Huang Y, Drisaldi B, Griffin EA Jr, Pollak DD, Xu S, Yin D, Schaffran C, Kandel DB & Kandel ER (2011). Molecular mechanism for a gateway drug: epigenetic changes initiated by nicotine prime gene expression by cocaine. Sci Transl Med 3, 107-109.
106. Li W, Doyon WM & Dani JA (2011). Acute in vivo nicotine administration enhances synchrony among dopamine neurons. Biochem Pharmacol 82, 977-983.
107. Lindsay GB & Rainey J (1997). Psychosocial and pharmacologic explanations of nicotine's "gateway drug" function. J Sch Health 67, 123-126.
108. Livingstone PD, Srinivasan J, Kew JN, Dawson LA, Gotti C, Moretti M, Shoaib M & Wonnacott S (2009). α7 and non-α7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortex. Eur J Neurosci 29, 539-550.
109. Luetje CW & Patrick J (1991). Both α- and β-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J Neurosci 11, 837-845.
110. Luna B, Padmanabhan A & O'Hearn K (2010). What has fMRI told us about the development of cognitive control through adolescence? Brain Cogn 72, 101-113.
111. Mameli-Engvall M, Evrard A, Pons S, Maskos U, Svensson TH, Changeux JP & Faure P (2006). Hierarchical control of dopamine neuron-firing patterns by nicotinic receptors. Neuron 50, 911-921.
112. Manitt C, Labelle-Dumais C, Eng C, Grant A, Mimee A, Stroh T & Flores C (2010). Peri-pubertal emergence of UNC-5 homologue expression by dopamine neurons in rodents. PLoS One 5, e11463.
113. Manitt C, Mimee A, Eng C, Pokinko M, Stroh T, Cooper HM, Kolb B & Flores C (2011). The netrin receptor DCC is required in the pubertal organization of mesocortical dopamine circuitry. J Neurosci 31, 8381-8394.
114. Mastwal S, Ye Y, Ren M, Jimenez DV, Martinowich K, Gerfen CR & Wang KH (2014). Phasic dopamine neuron activity elicits unique mesofrontal plasticity in adolescence. J Neurosci 34, 9484-9496.
115. Mathers M, Toumbourou JW, Catalano RF, Williams J & Patton GC (2006). Consequences of youth tobacco use: a review of prospective behavioral studies. Addiction 101, 948-958.
116. Matthews M, Bondi C, Torres G & Moghaddam B (2013). Reduced presynaptic dopamine activity in adolescent dorsal striatum. Neuropsychopharmacology 38, 1344-1351.
117. McCutcheon JE, Conrad KL, Carr SB, Ford KA, McGehee DS & Marinelli M (2012). Dopamine neurons in the ventral tegmental area fire faster in adolescent rats than in adults. J Neurophysiol 108, 1620-1630.
118. McCutcheon JE & Marinelli M (2009). Age matters. Eur J Neurosci 29, 997-1014.
119. McDonald CG, Eppolito AK, Brielmaier JM, Smith LN, Bergstrom HC, Lawhead MR & Smith RF (2007). Evidence for elevated nicotine-induced structural plasticity in nucleus accumbens of adolescent rats. Brain Res 1151, 211-218.
120. McGehee DS (1999). Molecular diversity of neuronal nicotinic acetylcholine receptors. Ann N Y Acad Sci 868, 565-577.
121. McKenzie M, Olsson CA, Jorm AF, Romaniuk H & Patton GC (2010). Association of adolescent symptoms of depression and anxiety with daily smoking and nicotine dependence in young adulthood: findings from a 10-year longitudinal study. Addiction 105, 1652-1659.
122. McQuown SC, Belluzzi JD & Leslie FM (2007). Low dose nicotine treatment during early adolescence increases subsequent cocaine reward. Neurotoxicol Teratol 29, 66-73.
123. McQuown SC, Dao JM, Belluzzi JD & Leslie FM (2009). Age-dependent effects of low-dose nicotine treatment on cocaine-induced behavioral plasticity in rats. Psychopharmacology (Berl) 207, 143-152.
124. Meeker JD (2012). Exposure to environmental endocrine disruptors and child development. Arch Pediatr Adolesc Med 166, E1-7.
125. Mitchell MR, Weiss VG, Beas BS, Morgan D, Bizon JL & Setlow B (2014). Adolescent risk taking, cocaine self-administration, and striatal dopamine signaling. Neuropsychopharmacology 39, 955-962.
126. Mojica CY, Dao JM, Yuan M, Loughlin SE & Leslie FM (2014). Nicotine modulation of adolescent dopamine receptor signaling and hypothalamic peptide response. Neuropharmacology 77, 285-293.
127. Moll GH, Mehnert C, Wicker M, Bock N, Rothenberger A, Rüther E & Huether G (2000). Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood. Dev Brain Res 119, 251-257.
128. Naneix F, Marchand AR, Di Scala G, Pape JR & Coutureau E (2012). Parallel maturation of goal-directed behavior and dopaminergic systems during adolescence. J Neurosci 32, 16223-16232.
129. 2 receptors alters the maturation of dopamine-dependent goal-directed behavior. Neuropsychopharmacology 38, 1566-1574.
130. Natividad LA, Torres OV, Friedman TC & O'Dell LE (2013). Adolescence is a period of development characterized by short- and long-term vulnerability to the rewarding effects of nicotine and reduced sensitivity to the anorectic effects of this drug. Behav Brain Res 257, 275-285.
131. Niwa M, Jaaro-Peled H, Tankou S, Seshadri S, Hikida T, Matsumoto Y, Cascella NG, Kano S, Ozaki N, Nabeshima T & Sawa A (2013). Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids. Science 339, 335-339.
132. O'Dell LE, Bruijnzeel AW, Smith RT, Parsons LH, Merves ML, Goldberger BA, Richardson HN, Koob GF & Markou A (2006). Diminished nicotine withdrawal in adolescent rats: implications for vulnerability to addiction. Psychopharmacology (Berl) 186, 612-619.
133. O'Donnell P (2010). Adolescent maturation of cortical dopamine. Neurotox Res 18, 306-312.
134. O'Loughlin J, Sylvestre MP, Labbe A, Low NC, Roy-Gagnon MH, Dugas EN, Karp I & Engert JC (2014). Genetic variants and early cigarette smoking and nicotine dependence phenotypes in adolescents. PLoS One 9, e115716.
135. Ostby Y, Tamnes CK, Fjell AM, Westlye LT, Due-Tonnessen P & Walhovd KB (2009). Heterogeneity in subcortical brain development: a structural magnetic resonance imaging study of brain maturation from 8 to 30 years. J Neurosci 29, 11772-11782.
136. Padmanabhan A, Geier CF, Ordaz SJ, Teslovich T & Luna B (2011). Developmental changes in brain function underlying the influence of reward processing on inhibitory control. Dev Cogn Neurosci 1, 517-529.
137. Papke RL & Heinemann SF (1991). The role of the β4-subunit in determining the kinetic properties of rat neuronal nicotinic acetylcholine α3-receptors. J Physiol 440, 95-112.
138. Paradise J (2014). Electronic cigarettes: smoke-free laws, sale restrictions, and the public health. Am J Public Health 104, e17-18.
139. Paus T (2010). Growth of white matter in the adolescent brain: Myelin or axon? Brain Cogn 72, 26-35.
140. Pentel PR, Keyler DE, Chen Y, LeSage MG, Dufek MB, Le C & Leslie FM (2006). Vaccination against nicotine does not prevent nicotine-induced changes in fetal nicotinic receptor binding and c-fos mRNA expression in rats. Neurotoxicol Teratol 28, 589-596.
141. Perry DC, Xiao Y, Nguyen HN, Musachio JL, Davila-Garcia MI & Kellar KJ (2002). Measuring nicotinic receptors with characteristics of α4β2, α3β2 and α3β4 subtypes in rat tissues by autoradiography. J Neurochem 82, 468-481.
142. Placzek AN, Zhang TA & Dani JA (2009). Age dependent nicotinic influences over dopamine neuron synaptic plasticity. Biochem Pharmacol 78, 686-692.
143. Philpot RM, Wecker L & Kirstein CL (2009). Repeated ethanol exposure during adolescence alters the developmental trajectory of dopaminergic output from the nucleus accumbens septi. Int J Dev Neurosci 27, 805-815.
144. Rashad I & Kaestner R (2004). Teenage sex, drugs and alcohol use: problems identifying the cause of risky behaviors. J Health Econ 23, 493-503.
145. Rehan VK, Liu J, Naeem E, Tian J, Sakurai R, Kwong K, Akbari O & Torday JS (2012). Perinatal nicotine exposure induces asthma in second generation offspring. BMC Med 10, 129.
146. Rubinov M & Sporns O (2010). Complex network measures of brain connectivity: uses and interpretations. Neuroimage 52, 1059-1069.
147. Substance Abuse and Mental Health Services Administration (2011). Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-41. HHS Publication No. (SMA) 11-4658. Substance Abuse and Mental Health Services Administration, Rockville, MD, USA.
148. Satterthwaite TD, Wolf DH, Erus G, Ruparel K, Elliott MA, Gennatas ED, Hopson R, Jackson C, Prabhakaran K, Bilker WB, Calkins ME, Loughead J, Smith A, Roalf DR, Hakonarson H, Verma R, Davatzikos C, Gur RC & Gur RE (2013). Functional maturation of the executive system during adolescence. J Neurosci 33, 16249-16261.
149. Schneider M (2013). Adolescence as a vulnerable period to alter rodent behavior. Cell Tissue Res 354, 99-106.
150. Schochet TL, Kelley AE & Landry CF (2005). Differential expression of arc mRNA and other plasticity-related genes induced by nicotine in adolescent rat forebrain. Neuroscience 135, 285-297.
151. Schultz W (2007). Behavioral dopamine signals. Trends Neurosci 30, 203-210.
152. Shearman E, Fallon S, Sershen H & Lajtha A (2008). Nicotine-induced monoamine neurotransmitter changes in the brain of young rats. Brain Res Bull 76, 626-639.
153. Shram MJ, Funk D, Li Z & Lê AD (2006). Periadolescent and adult rats respond differently in tests measuring the rewarding and aversive effects of nicotine. Psychopharmacology (Berl) 186, 201-208.
154. Shram MJ, Funk D, Li Z & Lê AD (2007). Acute nicotine enhances c-fos mRNA expression differentially in reward-related substrates of adolescent and adult rat brain. Neurosci Lett 418, 286-291.
155. Shram MJ, Siu EC, Li Z, Tyndale RF & Lê AD (2008). Interactions between age and the aversive effects of nicotine withdrawal under mecamylamine-precipitated and spontaneous conditions in male Wistar rats. Psychopharmacology (Berl) 198, 181-190.
156. Sisk CL & Zehr JL (2005). Pubertal hormones organize the adolescent brain and behavior. Front Neuroendocrinol 26, 163-174.
157. Slawecki CJ, Gilder A, Roth J & Ehlers CL (2003). Increased anxiety-like behavior in adult rats exposed to nicotine as adolescents. Pharmacol Biochem Behav 75, 355-361.
158. Slotkin TA (2004). Cholinergic systems in brain development and disruption by neurotoxicants: nicotine, environmental tobacco smoke, organophosphates. Toxicol Appl Pharmacol 198, 132-151.
159. Slotkin TA, Card J & Seidler FJ (2014). Nicotine administration in adolescence reprograms the subsequent response to nicotine treatment and withdrawal in adulthood: sex-selective effects on cerebrocortical serotonergic function. Brain Res Bull 102, 1-8.
160. Slotkin TA & Seidler FJ (2009). Nicotine exposure in adolescence alters the response of serotonin systems to nicotine administered subsequently in adulthood. Dev Neurosci 31, 58-70.
161. Smith LN, McDonald CG, Bergstrom HC, Brielmaier JM, Eppolito AK, Wheeler TL, Falco AM & Smith RF (2006). Long-term changes in fear conditioning and anxiety-like behavior following nicotine exposure in adult versus adolescent rats. Pharmacol Biochem Behav 85, 91-97.
162. A receptors and tonic inhibitory current during adolescence: effects on mood and synaptic plasticity. Front Neural Circuits 7, 135.
163. Sowell ER, Delis D, Stiles J & Jernigan TL (2001). Improved memory functioning and frontal lobe maturation between childhood and adolescence: a structural MRI study. J Int Neuropsychol Soc 7, 312-322.
164. Sowell ER, Thompson PM, Holmes CJ, Batth R, Jernigan TL & Toga AW (1999). Localizing age-related changes in brain structure between childhood and adolescence using statistical parametric mapping. Neuroimage 9, 587-597.
165. Spear LP (2000). The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24, 417-463.
166. Spear LP (2007). Assessment of adolescent neurotoxicity: rationale and methodological considerations. Neurotoxicol Teratol 29, 1-9.
167. Spear LP (2013). Adolescent neurodevelopment. J Adolesc Health 52, S7-13.
168. Spear LP (2015). Adolescent alcohol exposure: are there separable vulnerable periods within adolescence? Physiol Behav (in press, doi:10.1016/j.physbeh.2015.01.027)
169. Sturman D & Moghaddam B (2011). The neurobiology of adolescence: changes in brain architecture, functional dynamics, and behavioral tendencies. Neurosci Biobehav Rev 35, 1704-1712.
170. Sun SS, Schubert CM, Chumlea WC, Roche AF, Kulin HE, Lee PA, Himes JH & Ryan AS (2002). National estimates of the timing of sexual maturation and racial differences among US children. Pediatrics 110, 911-919.
171. Sussman S (2002). Effects of sixty six adolescent tobacco use cessation trials and seventeen prospective studies of self-initiated quitting. Tob Induc Dis 1, 35-81.
172. Tarazi FI, Tomasini EC & Baldessarini RJ (1998). Postnatal development of dopamine and serotonin transporters in rat caudate-putamen and nucleus accumbens septi. Neurosci Lett 254, 21-24.
173. Teicher MH, Andersen SL & Hostetter JC (1995). Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens. Dev Brain Res 89, 167-172.
174. Thomsen MS, Mikkelsen JD, Timmermann DB, Peters D, Hay-Schmidt A, Martens H & Hansen HH (2008). The selective α7 nicotinic acetylcholine receptor agonist A-582941 activates immediate early genes in limbic regions of the forebrain: Differential effects in the juvenile and adult rat. Neuroscience 154, 741-753.
175. Toll L, Zaveri NT, Polgar WE, Jiang F, Khroyan TV, Zhou W, Xie XS, Stauber GB, Costello MR & Leslie FM (2012). AT-1001: a high affinity and selective α3β4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats. Neuropsychopharmacology 37, 1367-1376.
176. Torres OV, Tejeda HA, Natividad LA & O'Dell LE (2008). Enhanced vulnerability to the rewarding effects of nicotine during the adolescent period of development. Pharmacol Biochem Behav 90, 658-663.
177. Trauth JA, Seidler FJ & Slotkin TA (2000). Persistent and delayed behavioral changes after nicotine treatment in adolescent rats. Brain Res 880, 167-172.
178. 2 dopamine receptors recruit a GABA component for their attenuation of excitatory synaptic transmission in the adult rat prefrontal cortex. Synapse 61, 843-850.
179. Tseng KY & O'Donnell P (2005). Post-pubertal emergence of prefrontal cortical up states induced by D1-NMDA co-activation. Cereb Cortex 15, 49-57.
180. U.S. Department of Health and Human Services (2014). The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA, USA.
181. Varlinskaya EI, Vetter-O'Hagen CS & Spear LP (2013). Puberty and gonadal hormones: role in adolescent-typical behavioral alterations. Horm Behav 64, 343-349.
182. Vastola BJ, Douglas LA, Varlinskaya EI & Spear LP (2002). Nicotine-induced conditioned place preference in adolescent and adult rats. Physiol Behav 77, 107-114.
183. Vetter-O'Hagen CS & Spear LP (2012). Hormonal and physical markers of puberty and their relationship to adolescent-typical novelty-directed behavior. Dev Psychobiol 54, 523-535.
184. Wahlstrom D, Collins P, White T & Luciana M (2010). Developmental changes in dopamine neurotransmission in adolescence: behavioral implications and issues in assessment. Brain Cogn 72, 146-159.
185. Wills TA, Knight R, Williams RJ, Pagano I & Sargent JD (2015). Risk factors for exclusive e-cigarette use and dual e-cigarette use and tobacco use in adolescents. Pediatrics 135, e43-51.
186. Winzer-Serhan UH & Leslie FM (1997). Codistribution of nicotinic acetylcholine receptor subunit α3 and β4 mRNAs during rat brain development. J Comp Neurol 386, 540-554.
187. Wong WC, Ford KA, Pagels NE, McCutcheon JE & Marinelli M (2013). Adolescents are more vulnerable to cocaine addiction: behavioral and electrophysiological evidence. J Neurosci 33, 4913-4922.
188. Xu Z, Seidler FJ, Cousins MM, Slikker W Jr & Slotkin TA (2002). Adolescent nicotine administration alters serotonin receptors and cell signaling mediated through adenylyl cyclase. Brain Res 951, 280-292.
189. Zhao-Shea R, Liu L, Soll LG, Improgo MR, Meyers EE, McIntosh JM, Grady SR, Marks MJ, Gardner PD & Tapper AR (2011). Nicotine-mediated activation of dopaminergic neurons in distinct regions of the ventral tegmental area. Neuropsychopharmacology 36, 1021-1032.
190. Zoli M, Le Novere N, Hill JA Jr & Changeux JP (1995). Developmental regulation of nicotinic ACh receptor subunit mRNAs in the rat central and peripheral nervous systems. J Neurosci 15, 1912-1939.